# DEMETRA - ADVICE-002-2022

> **NCT05394779** · NA · COMPLETED · sponsor: **Advice Pharma Group srl** · enrollment: 246 (actual)

## Conditions studied

- Obesity
- Health Behavior
- Life Style
- Dietary Habits
- Weight Loss
- Diet, Healthy
- Diet Habit
- Body Weight
- Nutrition Disorders
- Nutrition, Healthy
- Overweight and Obesity
- Behavioral Disorder

## Interventions

- **DEVICE:** DTXO APP
- **DEVICE:** PLACEBO APP - Control group

## Key facts

- **NCT ID:** NCT05394779
- **Lead sponsor:** Advice Pharma Group srl
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-23
- **Primary completion:** 2023-12-18
- **Final completion:** 2024-05-30
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2024-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05394779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05394779, "DEMETRA - ADVICE-002-2022". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05394779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*